Anusha Kalbasi

6.2k total citations · 1 hit paper
62 papers, 2.6k citations indexed

About

Anusha Kalbasi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Anusha Kalbasi has authored 62 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 32 papers in Pulmonary and Respiratory Medicine and 20 papers in Immunology. Recurrent topics in Anusha Kalbasi's work include Sarcoma Diagnosis and Treatment (24 papers), Immunotherapy and Immune Responses (12 papers) and CAR-T cell therapy research (12 papers). Anusha Kalbasi is often cited by papers focused on Sarcoma Diagnosis and Treatment (24 papers), Immunotherapy and Immune Responses (12 papers) and CAR-T cell therapy research (12 papers). Anusha Kalbasi collaborates with scholars based in United States, United Kingdom and Italy. Anusha Kalbasi's co-authors include Antoni Ribas, Naomi B. Haas, Neha Vapiwala, Carl H. June, Mingen Liu, Gregory L. Beatty, Chad A. Komar, Jae W. Lee, Edgar Ben‐Josef and Whitney L. Gladney and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Anusha Kalbasi

56 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumour-intrinsic resistance to immune checkpoint blockade

2019 1.0k citations Anusha Kalbasi, Antoni Ribas profile →

Peers

Countries citing papers authored by Anusha Kalbasi

Since Specialization

Citations

This map shows the geographic impact of Anusha Kalbasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anusha Kalbasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anusha Kalbasi more than expected).

Fields of papers citing papers by Anusha Kalbasi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anusha Kalbasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anusha Kalbasi. The network helps show where Anusha Kalbasi may publish in the future.

Co-authorship network of co-authors of Anusha Kalbasi

This figure shows the co-authorship network connecting the top 25 collaborators of Anusha Kalbasi. A scholar is included among the top collaborators of Anusha Kalbasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anusha Kalbasi. Anusha Kalbasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association of Histologic Subtype With Radiation Response and Survival Outcomes in Synovial Sarcoma 2025 ·Advances in Radiation Oncology ·Jennifer K. Matsui, Scott Jackson, (unknown), David G. Mohler, Robert Steffner, Raffi S. Avedian, Gregory W. Charville, Matt van de Rijn, Lynn Million, Alexander L. Chin, Susan M. Hiniker, Anusha Kalbasi, Everett J. Moding	0
2	Expanding the cytokine receptor alphabet reprograms T cells into diverse states 2025 ·Nature ·Yang Zhao, Masato Ogishi, Ankita Pal, Leon Su, (unknown), Hua Jiang, (unknown), Xiaojing Chen, Qinli Sun, (unknown), (unknown), Deepa Waghray, Anusha Kalbasi, K. Christopher García	2
3	SCAN-ACT: adoptive T cell therapy target discovery through single-cell transcriptomics 2025 ·Genome Medicine ·(unknown), (unknown), (unknown), Sushama Varma, Jack Pengfei Tang, Danielle Graham, (unknown), Minggui Pan, Nam Q. Bui, Kristen N. Ganjoo, Sarah Dry, Paul H. Huang, Matt van de Rijn, Wei Jiang, Anusha Kalbasi, Everett J. Moding	0
4	A Phase II Trial of 5-Day Neoadjuvant Radiation Therapy for Patients with High-Risk Primary Soft Tissue Sarcoma: Long-Term Follow-Up and Outcomes 2024 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), Ricky R. Savjani, Nicholas Jackson, Jie Deng, (unknown), (unknown), Brian E. Kadera, Joseph G. Crompton, Lucas M. Wessel, Bartosz Chmielowski, Arun S. Singh, Scott D. Nelson, Sarah Dry, Joanne B. Weidhaas, Michael L. Steinberg, Nicholas M. Bernthal, Frederick C. Eilber, Anusha Kalbasi, Vishruth K. Reddy	1
5	Targeted Bias: The Next Swing at IL2 Therapy 2024 ·Cancer Discovery ·(unknown), Anusha Kalbasi	2
6	Effect of palliative radiation dose on symptom response in metastatic sarcomas 2024 ·Clinical and Translational Radiation Oncology ·Jennifer K. Matsui, Scott Jackson, (unknown), Lynn Million, Alexander L. Chin, Susan M. Hiniker, Anusha Kalbasi, Everett J. Moding	0
7	Antitumor Immune Responses in B2M -Deficient Cancers 2023 ·Cancer Immunology Research ·Davis Y. Torrejon, (unknown), Gabriel Abril-Rodríguez, Katie M. Campbell, Egmidio Medina, Agustin Vega-Crespo, Anusha Kalbasi, Begoña Comı́n-Anduix, Antoni Ribas	22
8	IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma 2023 ·Cancers ·(unknown), Jack Pengfei Tang, (unknown), Serena Lofftus, (unknown), (unknown), (unknown), Lucia Chen, Manando Nakasaki, Sarah Dry, Joseph G. Crompton, Fritz C. Eilber, Dinesh S. Rao, Anusha Kalbasi, Brian E. Kadera	3
9	Surgical Outcomes in Patients Treated with 5-Day Preoperative Radiotherapy for Soft Tissue Sarcoma 2023 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), Ricky R. Savjani, Lucas M. Wessel, Jie Deng, Joseph G. Crompton, Nicholas M. Bernthal, Fritz C. Eilber, Vishruth K. Reddy, Anusha Kalbasi	2
10	Retrospective analysis of adjuvant treatment for localized, operable uterine leiomyosarcoma 2022 ·Cancer Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Joshua G. Cohen, Bartosz Chmielowski, Anusha Kalbasi, J. Sunil Rao, Scott D. Nelson, Arun S. Singh	4
11	Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy 2022 ·Proceedings of the National Academy of Sciences ·Lawrence A. Stern, Sharareh Gholamin, Ignacio Moraga, Xin Yang, (unknown), Joseph R. Cohen, Renate Starr, Brenda Aguilar, (unknown), (unknown), Anusha Kalbasi, Jennifer Kelly Shepphird, (unknown), K. Christopher García, Christine E. Brown	18
12	A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma 2020 ·Clinical Cancer Research ·Anusha Kalbasi, Mitchell Kamrava, Fang‐I Chu, Donatello Telesca, (unknown), Yingli Yang, Dan Ruan, Scott D. Nelson, Sarah Dry, Jackie Hernandez, Bartosz Chmielowski, Arun S. Singh, Susan V. Bukata, Nicholas M. Bernthal, Michael L. Steinberg, Joanne B. Weidhaas, Fritz C. Eilber	77
13	Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma 2020 ·Science Translational Medicine ·Anusha Kalbasi, (unknown), Kevin Hakimi, Sarah Kremer, Katie M. Campbell, Juan M. Funes, Agustin Vega-Crespo, Giulia Parisi, (unknown), Christine Nguyen, Davis Y. Torrejon, Daniel Sanghoon Shin, Jesse M. Zaretsky, Robert Damoiseaux, Daniel E. Speiser, Pedro P. López‐Casas, Marisol Quintero, Antoni Ribas	79
14	Tumor Size Matters—Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy 2020 ·Cancers ·(unknown), Mi-Heon Lee, Christine Nguyen, Anusha Kalbasi, James Sayre, Tahmineh Romero, P. Nickers, William H. McBride, Dörthe Schaue	17
15	Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIs 2020 ·Physics in Medicine and Biology ·Yu Gao, Anusha Kalbasi, William Hsu, Dan Ruan, Jie Fu, Jiaxin Shao, Minsong Cao, Chenyang Wang, Fritz C. Eilber, Nicholas M. Bernthal, Susan V. Bukata, Sarah Dry, Scott D. Nelson, Mitchell Kamrava, John H. Lewis, Daniel A. Low, Michael L. Steinberg, Peng Hu, Yingli Yang	43
16	Personalized medicine in breast cancer: pharmacogenomics approaches 2019 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Anusha Kalbasi, (unknown), (unknown), Alireza Rezvani, Hakimeh Zali	27
17	SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study 2018 ·Cancer Discovery ·Antoni Ribas, Theresa Medina, Shivaani Kummar, Asim Amin, Anusha Kalbasi, Joseph J. Drabick, Minal Barve, Gregory A. Daniels, Deborah Jean Lee Wong, Emmett V. Schmidt, Albert F. Candia, Robert L. Coffman, Abraham C.F. Leung, Robert S. Janssen	237
18	5-Day Hypofractionated Preoperative Radiation Therapy in Soft Tissue Sarcoma: Preliminary Toxicity and Pathologic Outcomes from a Prospective Phase 2 Study 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Anusha Kalbasi, Mitchell Kamrava, Scott D. Nelson, Sarah Dry, (unknown), Bartosz Chmielowski, Arun S. Singh, Noah Federman, Susan V. Bukata, Nicholas M. Bernthal, Michael L. Steinberg, Fritz C. Eilber	3
19	Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma 2016 ·Clinical Cancer Research ·Anusha Kalbasi, Chad A. Komar, Graham M. Tooker, Mingen Liu, Jae W. Lee, Whitney L. Gladney, Edgar Ben‐Josef, Gregory L. Beatty	248
20	Prevention of Interleukin-2 Withdrawal-Induced Apoptosis in Lymphocytes Retrovirally Cotransduced With Genes Encoding an Antitumor T-cell Receptor and an Antiapoptotic Protein 2010 ·Journal of Immunotherapy ·Anusha Kalbasi, Rajeev Shrimali, Dhanalakshmi Chinnasamy, Steven A. Rosenberg	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact